LK
ELV icon

Lumbard & Kellner’s Elevance Health ELV Stock Holding History

Lumbard & Kellner’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,200
Closed -$720K – 82
2017
Q4 		$720K Sell
3,200
-125
-4% -$26.6K 0.37% 44
2017
Q3 		$631K Hold
3,325
– – 0.34% 51
2017
Q2 		$626K Sell
3,325
-1,844
-36% -$331K 0.36% 48
2017
Q1 		$855K Buy
+5,169
New +$822K 0.51% 41

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lumbard & Kellner's ELV Position: Q1 2018 in Review

Lumbard & Kellner sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 3,200 shares — an estimated $720K sold.

Lumbard & Kellner first reported a position in ELV in Q1 2017 and held it in 4 quarters. The position peaked at $855K in Q1 2017. 922 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

  • Lumbard & Kellner reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
  • Lumbard & Kellner sold 3,200 Elevance Health shares in Q1 2018, an estimated $720K.
  • Lumbard & Kellner first reported a position in Elevance Health in Q1 2017 and held it in 4 quarters.
  • Lumbard & Kellner's Elevance Health position peaked at $855K in Q1 2017.
  • 922 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on Lumbard & Kellner's 13F filing for Q1 2018, filed 2 May 2018.